Showing 81 - 100 results of 8,767 for search '"neurodegenerative disorders"', query time: 0.24s Refine Results
  1. 81
  2. 82
  3. 83

    Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders by Sapana Chaudhary, Sameer Chaudhary, Sakshi Rawat, Archana Kulkarni, Anwar L. Bilgrami, Asma Perveen, Badrah S. Alghamdi, Torki Al Zughaibi, Ghulam Md Ashraf, Mohammad Zubair Alam, Tabish Hussain

    Published 2022-09-01
    “…Due to the rise in the elderly population, age-dependent neurodegenerative disorders are becoming increasingly prevalent. …”
    Get full text
    Article
  4. 84

    Circulating miRNAs as Biomarkers for Neurodegenerative Disorders by Margherita Grasso, Paola Piscopo, Annamaria Confaloni, Michela A. Denti

    Published 2014-05-01
    “…Neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and frontotemporal dementias (FTD), are considered distinct entities, however, there is increasing evidence of an overlap from the clinical, pathological and genetic points of view. …”
    Get full text
    Article
  5. 85

    Melatonin in Alzheimer's disease and other neurodegenerative disorders by Poeggeler B, Cardinali DP, Pandi-Perumal SR, Srinivasan V, Hardeland R

    Published 2006-05-01
    “…<p>Abstract</p> <p>Increased oxidative stress and mitochondrial dysfunction have been identified as common pathophysiological phenomena associated with neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). …”
    Get full text
    Article
  6. 86

    Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship? by Daniele Urso, Daniele Urso, Valentina Gnoni, Valentina Gnoni, Marco Filardi, Marco Filardi, Giancarlo Logroscino, Giancarlo Logroscino

    Published 2022-01-01
    “…A more extensive characterization of the relationship between delusions and delirium may help to understand whether delusions may constitute a risk factor for delirium and may ameliorate the management of both conditions in patients with neurodegenerative disorders.…”
    Get full text
    Article
  7. 87
  8. 88
  9. 89
  10. 90

    Prions and Prion-Like Pathogens in Neurodegenerative Disorders by Caterina Peggion, Maria Catia Sorgato, Alessandro Bertoli

    Published 2014-02-01
    “…They have been identified as self-replicating proteinaceous agents responsible for the onset of rare and fatal neurodegenerative disorders—known as transmissible spongiform encephalopathies, or prion diseases—which affect humans and other animal species. …”
    Get full text
    Article
  11. 91
  12. 92
  13. 93

    Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders by Jessica Cohen, Annette Mathew, Kirk D. Dourvetakis, Estella Sanchez-Guerrero, Rajendra P. Pangeni, Narasimman Gurusamy, Kristina K. Aenlle, Geeta Ravindran, Assma Twahir, Dylan Isler, Sara Rukmini Sosa-Garcia, Axel Llizo, Alison C. Bested, Theoharis C. Theoharides, Nancy G. Klimas, Duraisamy Kempuraj

    Published 2024-03-01
    “…Neuroinflammatory and neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), traumatic brain injury (TBI) and Amyotrophic lateral sclerosis (ALS) are chronic major health disorders. …”
    Get full text
    Article
  14. 94
  15. 95
  16. 96

    An interactive review on the role of Tocotrienols in the neurodegenerative disorders by Naomi, Ruth, Shafie, Nurul Husna, Kaniappan, Priyatharisni, Bahari, Hasnah

    Published 2021
    “…Neurodegenerative disorders, such as Parkinson's and Alzheimer's disease, are claimed to be of major concern causing a significant disease burden worldwide. …”
    Article
  17. 97

    Transposable elements in TDP-43-mediated neurodegenerative disorders. by Wanhe Li, Ying Jin, Lisa Prazak, Molly Hammell, Josh Dubnau

    Published 2012-01-01
    “…Elevated expression of specific transposable elements (TEs) has been observed in several neurodegenerative disorders. TEs also can be active during normal neurogenesis. …”
    Get full text
    Article
  18. 98
  19. 99

    Need to improve clinical trials in rare neurodegenerative disorders by Maria Puopolo, Maurizio Pocchiari

    Published 2011-01-01
    “…The adoption of innovative statistical approaches in early Phase II trials might improve the screening of drugs in rare neurodegenerative disorders, but this implicates efforts from clinical researchers, statisticians, and regulatory people to the development of new strategies that should maintain rigorous scientific integrity together with a more ethical approach to human experimentations.…”
    Get full text
    Article
  20. 100

    Linking Puberty and the Gut Microbiome to the Pathogenesis of Neurodegenerative Disorders by Pasquale Esposito, Nafissa Ismail

    Published 2022-10-01
    “…Due to the maturation of these fundamental systems, this is a period of development that is particularly sensitive to stressors, increasing susceptibility to neurodevelopmental and neurodegenerative disorders later in life. The gut microbiome plays a critical role in the regulation of stress and immune responses, and gut dysbiosis has been implicated in the development of neurodevelopmental and neurodegenerative disorders. …”
    Get full text
    Article